The LATAM Advantage

How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks of running studies in this region. Julio Martinez-Clark, CEO of BioAccess explores the growth of clinical research in Latin America. With deep Colombian roots and connections across the region, they established BioAccess to help U.S. medtech and biopharma startups accelerate early-stage studies in Latin America.

Julio highlights advantages such as lower costs, faster regulatory approvals in countries like Panama and Chile, and high-quality research from certified sites. He emphasizes that success depends on partnering with experienced local experts, as navigating fragmented regulatory systems without guidance can lead to delays or missteps. The conversation also touches on industry trends, including private equity investment, expanding site networks, and new laws across Latin America designed to attract foreign research.